Skip to main content

Table 1 General characteristics of patients across insulin resistance presence

From: Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study

  NIRG (n = 176) IRG (n = 183)  
n % n % p
Sex
 Males 156 88,60% 105 57,40% 0.005
Physical activity
 Sedentary 105 59,70% 117 64,60% 0.595
 Active 71 40,30% 66 36,50%  
Clinical characteristics
 Previous myocardial revascularization 142 81% 142 78% 0.472
 Hypertension 166 94% 179 98% 0.09
 Type 2 diabetes mellitus 81 46% 98 54% 0.154
 Dyslipidemia 155 88% 161 88% 0.979
 CVD family history 131 74% 127 69% 0.299
Smoking status
 Current smoker 11 6% 11 6% 0.864
 Former smoker 97 55% 106 58%  
 Nonsmoker 68 39% 66 36%  
Drugs in use
 Acetylsalicylic acid 165 94% 171 93% 0.905
 Clopidogrel 11 6% 20 11% 0.114
 Beta-blocker 152 86% 155 85% 0.654
 Thiazide diuretics 38 22% 56 31% 0.06
 ACE inhibitors 86 49% 88 48% 0.883
 Angiotensin receptor blockers 47 27% 64 35% 0.09
 Calcium channel blockers 38 22% 63 34% 0.006
 Statin 166 94% 164 90% 0.102
 Metformin 71 40% 82 45% 0.392
 Insulin 23 13% 38 21% 0.05
  1. IRG group of patients with insulin resistance, NIRG group of patients non-insulin resistant, CVD cardiovascular disease, ACE inhibitors angiotensin-converting-enzyme inhibitor